Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization

Cheah AL, Spelman T, Liew D, Peel T, Howden BP, Spelman D, Grayson ML, Nation RL, Kong DC

(2013), Clin Microbiol Infect, 19(4), E181-9

Comparing short versions of the AUDIT in a community-based survey of young people

Bowring AL, Gouillou M, Hellard M, Dietze P

(2013), BMC Public Health, 13(1), 301

Quantitative HBsAg and HBeAg predict hepatitis B seroconversion after initiation of HAART in HIV-HBV coinfected individuals

Matthews GV, Ali RJ, Avihingsanon A, Amin J, Hammond R, Bowden S, Lewin SR, Sasadeusz J, Littlejohn M, Locarnini SL, Ruxrungtham K, Dore GJ

(2013), PLoS One, 8(4), e61297

Characterization of tetraspanins CD9, CD53, CD63, and CD81 in monocytes and macrophages in HIV-1 infection

Tippett E, Cameron PU, Marsh M, Crowe SM

(2013), J Leukoc Biol, 93(6), 913-20

Sexual health promotion on social networking sites: a process evaluation of The FaceSpace Project

Nguyen P, Gold J, Pedrana A, Chang S, Howard S, Ilic O, Hellard M, Stoove

(2013), J Adolesc Health, 53(1), 98-104

The NRTIs lamivudine, stavudine and zidovudine have reduced HIV-1 inhibitory activity in astrocytes

Gray LR, Tachedjian G, Ellett AM, Roche MJ, Cheng WJ, Guillemin GJ, Brew BJ, Turville SG, Wesselingh SL, Gorry PR, Churchill MJ

(2013), PLoS One, 8(4), e62196

The magnitude of HIV-1 resistance to the CCR5 antagonist maraviroc may impart a differential alteration in HIV-1 tropism for macrophages and T-cell subsets

Flynn JK, Paukovics G, Moore MS, Ellett A, Gray LR, Duncan R, Salimi H, Jubb B, Westby M, Purcell DF, Lewin SR, Lee B, Churchill MJ, Gorry PR, Roche M

(2013), Virology, 442(1), 51-8

A common mechanism of clinical HIV-1 resistance to the CCR5 antagonist maraviroc despite divergent resistance levels and lack of common gp120 resistance mutations

Roche M, Salimi H, Duncan R, Wilkinson BL, Chikere K, Moore MS, Webb NE, Zappi H, Sterjovski J, Flynn JK, Ellett A, Gray LR, Lee B, Jubb B, Westby M, Ramsland PA, Lewin SR, Payne RJ, Churchill MJ, Gorry PR

(2013), Retrovirology, 10, 43

Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial

Morrissey CO, Chen SC, Sorrell TC, Milliken S, Bardy PG, Bradstock KF, Szer J, Halliday CL, Gilroy NM, Moore J, Schwarer AP, Guy S, Bajel A, Tramontana AR, Spelman T, Slavin MA; Australasian Leukaemia Lymphoma Group and the Australia and New Zealand Mycol

(2013), Lancet Infect Dis, 13(6), 519-28

Maintenance of Th1 hepatitis C virus (HCV)-specific responses in individuals with acute HCV who achieve sustained virological clearance after treatment

Flynn JK, Dore GJ, Hellard M, Yeung B, Rawlinson WD, White PA, Kaldor JM, Lloyd AR, Ffrench RA; ATAHC Study Group

(2013), J Gastroenterol Hepatol, 28(11), 1770-81

An unusual case of HIV virologic failure during treatment with boosted atazanavir

Duncan A, Mills J

(2013), AIDS, 27(8), 1361-2

HIV epidemic in men who have sex with men in Philippines

Ross AG, Ditangco RA, Belimac JG, Olveda RM, Mercado ES, Rogers GD, Cripps AW, Lam A, Crowe SM

(2013), Lancet Infect Dis, 13(6), 472-3

Characteristics of a sexual network of behaviorally bisexual men in Vientiane, Lao PDR, 2010

van Gemert C, Vongsaiya K, Hughes C, Jenkinson R, Bowring AL, Sihavong A, Phimphachanh C, Chanlivong N, Toole M, Hellard M

(2013), AIDS Educ Prev, 25(3), 232-43

Longitudinal analysis of CCR5 and CXCR4 usage in a cohort of antiretroviral therapy-naive subjects with progressive HIV-1 subtype C infection

Jakobsen MR, Cashin K, Roche M, Sterjovski J, Ellett A, Borm K, Flynn J, Erikstrup C, Gouillou M, Gray LR, Saksena NK, Wang B, Purcell DF, Kallestrup P, Zinyama-Gutsire R, Gomo E, Ullum H, Ostergaard L, Lee B, Ramsland PA, Churchill MJ, Gorry PR

(2013), PLoS One, 8(6), e65950

Cryptococcosis-IRIS is associated with lower cryptococcus-specific IFN-γ responses before antiretroviral therapy but not higher T-cell responses during therapy

Chang CC, Lim A, Omarjee S, Levitz SM, Gosnell BI, Spelman T, Elliott JH, Carr WH, Moosa MY, Ndung'u T, Lewin SR, French MA

(2013), J Infect Dis, 208(6), 898-906

A cure for HIV: where we've been, and where we're headed

Lewin SR

(2013), Lancet, 381(9883), 2057-8

HIV and co-infections

Chang CC, Crane M, Zhou J, Mina M, Post JJ, Cameron BA, Lloyd AR, Jaworowski A, French MA, Lewin SR

(2013), Immunol Rev, 254(1), 114-42

Introduction of a sexual health practice nurse is associated with increased STI testing of men who have sex with men in primary care

Snow AF, Vodstrcil LA, Fairley CK, El-Hayek C, Cummings R, Owen L, Roth N, Hellard ME, Chen MY

(2013), BMC Infect Dis, 13, 298

Altering cell death pathways as an approach to cure HIV infection

Badley AD, Sainski A, Wightman F, Lewin SR

(2013), Cell Death Dis, 4, e718

Impact of HIV-associated conditions on mortality in people commencing anti-retroviral therapy in resource limited settings

Marshall CS, Curtis AJ, Spelman T, O'Brien DP, Greig J, Shanks L, du Cros P, Casas EC, da Fonseca MS, Athan E, Elliott JH

(2013), PLoS One, 8(7), e68445

36 37 38 39 40